Particle Engineering for Pulmonary Drug Delivery
The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Nanosuspensions in drug delivery
Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,524
Large Porous Particles for Pulmonary Drug Delivery
Edwards, D. A., Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, M. L., Mintzes, J., Deaver, D., Lotan, N., & Langer, R. (1997) · Science · doi:10.1126/science.276.5320.1868 · Cited by 1,174
Particle Size Analysis in Pharmaceutics: Principles, Methods and Applications
Shekunov, B. Y., Chattopadhyay, P., Tong, H. H. Y., & Chow, A. H. L. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9146-7 · Cited by 545
Self-citationMicroencapsulated chitosan nanoparticles for lung protein delivery
Grenha, A., Seijo, B., & Remuñán-López, C. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.04.009 · Cited by 469
Ultrafine Particle–Lung Interactions: Does Size Matter?
Kreyling, W. G., Semmler-Behnke, M., & Möller, W. (2006) · Journal of Aerosol Medicine · doi:10.1089/jam.2006.19.74 · Cited by 394
Micron‐Size Drug Particles: Common and Novel Micronization Techniques
Rasenack, N., & Müller, B. W. (2004) · Pharmaceutical Development and Technology · doi:10.1081/pdt-120027417 · Cited by 357
Protein Inhalation Powders: Spray Drying vs Spray Freeze Drying
Maa, Y.-F., Nguyen, P.-A., Sweeney, T., Shire, S. J., & Hsu, C. C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018828425184 · Cited by 356
Evolution of dry powder inhaler design, formulation, and performance
NEWMAN, S. P., & BUSSE, W. W. (2002) · Respiratory Medicine · doi:10.1053/rmed.2001.1276 · Cited by 340
Formulation and Physical Characterization of Large Porous Particles for Inhalation
Vanbever, R., Mintzes, J. D., Wang, J., Nice, J., Chen, D., Batycky, R., Langer, R., & Edwards, D. A. (1999) · Pharmaceutical Research · doi:10.1023/a:1018910200420 · Cited by 314
Cited by
Danaei, M., Dehghankhold, M., Ataei, S., Hasanzadeh Davarani, F., Javanmard, R., Dokhani, A., Khorasani, S., & Mozafari, M. R. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10020057 · Cited by 4,832
Pharmaceutical Particle Engineering via Spray Drying
Vehring, R. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9475-1 · Cited by 1,691
Formulation strategy and use of excipients in pulmonary drug delivery
Pilcer, G., & Amighi, K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.017 · Cited by 791
Polysaccharide-based aerogels—Promising biodegradable carriers for drug delivery systems
García-González, C. A., Alnaief, M., & Smirnova, I. (2011) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2011.06.066 · Cited by 725
Influence of particle size on regional lung deposition – What evidence is there?
Carvalho, T. C., Peters, J. I., & Williams III, R. O. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.040 · Cited by 614
Nanomedicine in pulmonary delivery
Mansour, H., Haemosu, & Wu, X. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s4937 · Cited by 485
Thorat, A. A., & Dalvi, S. V. (2012) · Chemical Engineering Journal · doi:10.1016/j.cej.2011.12.044 · Cited by 438
Advances in nanomaterial-based targeted drug delivery systems
Cheng, X., Xie, Q., & Sun, Y. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1177151 · Cited by 395
Ultrafine Particle–Lung Interactions: Does Size Matter?
Kreyling, W. G., Semmler-Behnke, M., & Möller, W. (2006) · Journal of Aerosol Medicine · doi:10.1089/jam.2006.19.74 · Cited by 394
Delivery strategies for sustained drug release in the lungs
Loira-Pastoriza, C., Todoroff, J., & Vanbever, R. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.017 · Cited by 393
Ziaee, A., Albadarin, A. B., Padrela, L., Femmer, T., O'Reilly, E., & Walker, G. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.10.026 · Cited by 366
Materials and methods for delivery of biological drugs
Zelikin, A. N., Ehrhardt, C., & Healy, A. M. (2016) · Nature Chemistry · doi:10.1038/nchem.2629 · Cited by 315
Inhalation drug delivery devices: technology update
Garcia-Contreras, L., Ibrahim, M., & Verma, R. (2015) · Medical Devices: Evidence and Research · doi:10.2147/mder.s48888 · Cited by 306
Dry powder inhalers (DPIs)—A review of device reliability and innovation
Islam, N., & Gladki, E. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.044 · Cited by 298
Tissue accumulation of microplastics and potential health risks in human
Zhu, L., Kang, Y., Ma, M., Wu, Z., Zhang, L., Hu, R., Xu, Q., Zhu, J., Gu, X., & An, L. (2024) · Science of The Total Environment · doi:10.1016/j.scitotenv.2024.170004 · Cited by 286
Targeted Drug-Aerosol Delivery in the Human Respiratory System
Kleinstreuer, C., Zhang, Z., & Donohue, J. F. (2008) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.10.061807.160544 · Cited by 267
Biodegradable polymeric nanocarriers for pulmonary drug delivery
Rytting, E., Nguyen, J., Wang, X., & Kissel, T. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.6.629 · Cited by 266
Controlled pulmonary drug and gene delivery using polymeric nano-carriers
Beck-Broichsitter, M., Merkel, O. M., & Kissel, T. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.004 · Cited by 200
The formulation of nanomedicines for treating tuberculosis
Costa, A., Pinheiro, M., Magalhães, J., Ribeiro, R., Seabra, V., Reis, S., & Sarmento, B. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.012 · Cited by 123
Yan, A., Von Dem Bussche, A., Kane, A. B., & Hurt, R. H. (2007) · Carbon · doi:10.1016/j.carbon.2007.08.035 · Cited by 95
“Greater biocompatibility can be achieved by some natural dispersants such as bovine serum albumin (BSA), chitosan, or dipalmitoylphosphatidylcholine (DPPC) [6,13,14], but being biological materials these are subject to bacterial contamination if processed under non-sterile conditions and are not attractive for many no…”
BackgroundPatil-Gadhe, A., Kyadarkunte, A., Patole, M., & Pokharkar, V. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.07.007 · Cited by 84
“Also, large particles exhibit slower phagocytic clearance and therefore are long lasting at low dose [51].”
Background
Metadata
- Authors
- Chow, A. H. L., Tong, H. H. Y., Chattopadhyay, P., & Shekunov, B. Y.
- Venue
- Pharmaceutical Research
- Published
- 2007-01-24
- Volume
- 24
- Issue
- 3
- Pages
- 411-437
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1975132504
- Cited by
- 645
- References
- 101
- FWCI
- 20.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.